- Home
- LLY vs UL Comparison
LLY vs UL Comparison
Compare LLY & UL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LLY | UL |
|---|---|---|
| Founded | 1876 | 1930 |
| Country | United States | United Kingdom |
| Employees | N/A | 96092 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.6B | 127.2B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | LLY | UL |
|---|---|---|
| Price | $907.32 | $58.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $1,217.79 | N/A |
| AVG Volume (30 Days) | 2.3M | ★ 5.4M |
| Earning Date | 04-30-2026 | 07-28-2026 |
| Dividend Yield | 0.75% | ★ 3.97% |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 22.95 | N/A |
| Revenue | ★ $65,179,000,000.00 | N/A |
| Revenue This Year | $26.98 | $2.60 |
| Revenue Next Year | $15.83 | $3.70 |
| P/E Ratio | $40.14 | ★ $14.29 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $54.95 |
| 52 Week High | $1,133.95 | $74.98 |
Technical Indicators
Market Signals| Indicator | LLY | UL |
|---|---|---|
| Relative Strength Index (RSI) | 40.42 | 36.54 |
| Support Level | $877.11 | $55.00 |
| Resistance Level | $1,102.49 | $61.41 |
| Average True Range (ATR) | 27.52 | 0.96 |
| MACD | 3.27 | 0.39 |
| Stochastic Oscillator | 29.66 | 52.82 |
Price Performance
Historical ComparisonAbout LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
About UL Unilever PLC
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.